Skip to content

Clinical intervention study with food (strawberries [Erdbeeren], ...) for biomarker identification for the extension of health by rejuvenation

Clinical intervention study with food (strawberries [Erdbeeren], ...) for biomarker identification for the extension of health by rejuvenation - ErdBEHR-2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026998
Enrollment
180
Registered
2022-10-19
Start date
2021-06-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GENERAL HEALTH

Interventions

Group 1: Fresh strawberries 500 g/week Group 2: Fresh strawberries 2500 g/week (first week 1500g, last week 3750g). Group 3: Fresh strawberries 2500 g/week (first week 1500g, last week 3750g) Freeze-

Sponsors

Universitätsmedizin Rostock, Institut für Biostatistik und Informatik in Medizin und Alternsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: • Accessible strawberry salespoint • No or moderate intake of dietary supplements/vitamins • No shift work • Consumption of the tested foods in the past • Weight < 100kg • Regular influenza vaccination (planned but not considered (*)) (*) Citation of ethics application: "Should it be clear at the the start of the study that the recruitment goal cannot be achieved with the given inclusion criteria, the inclusion criteria will be dropped or softened in their order from bottom to top." We could only apply the first 5 criteria.

Exclusion criteria

Exclusion criteria: • known food allergy/intolerance in the subject, food allergy/intolerance to strawberries in the subject or 1st degree relatives; • prescription drugs (except cholesterol-lowering drugs, antihypertensive drugs, thyroid drugs) / severe chronic diseases (e.g. cancer, diabetes, autoimmune diseases).

Design outcomes

Primary

MeasureTime frame
Changes in the biomarkers C-reactive protein (hs-CRP) and LDL cholesterol, as defined in the ethics application dated 4/16/2021.

Secondary

MeasureTime frame
Change in other biomarkers (if available): HDL cholesterol, total cholesterol, triglycerides, HOMA-IR, "Phenotypic Age", IL6 & sTNFr1, GDF15, GrimAge, and other exploratory biomarkers (the preceding list was defined in the ethics application dated 04/16/2021).

Countries

Germany

Contacts

Public ContactMichael Walter

Universitätsmedizin Rostock, Institut für Klinische Chemie und Laboratoriumsmedizin

michael.walter@med.uni-rostock.de+49(0)381-4947655

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026